SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G/A
Under the Securities Exchange Act of 1934
(Amendment No. 4)
GENSIA, INC.
----------------------------
(Name of Issuer)
Common Stock par value $.01 per share
- ---------------------------------------------------------------------------
(Title of Class of Securities)
372450 10 6
-----------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement [ ].
Page 1 of 4
There is no Exhibit Index
<PAGE> 2
CUSIP No. 372450 10 6
___________________________________________________________________________
1) Name of Reporting Person and its Hoechst Marion Roussel, Inc.
I.R.S. Identification Number 44-0565557
___________________________________________________________________________
2) Check the Appropriate Box if (a)[ ]
a Member of a Group (b)[ x ]
___________________________________________________________________________
3) SEC Use Only
___________________________________________________________________________
4) Citizenship or Place of Organization Delaware
___________________________________________________________________________
5) Sole Voting Power 3,396,442
Number of ____________________________________________________________
Shares
Beneficially 6) Shared Voting Power 0
Owned by ____________________________________________________________
Each
Reporting 7) Sole Dispositive Power 3,396,442
Person With ____________________________________________________________
8) Shared Dispositive Power 0
___________________________________________________________________________
9) Aggregate Amount Beneficially Owned 3,396,442
by Each Reporting Person
___________________________________________________________________________
10) Check Box If the Aggregate Amount [ ]
in Row (9) Excludes Certain Shares
___________________________________________________________________________
11) Percent of Class Represented 8.4%
by Amount in Row (9)
___________________________________________________________________________
12) Type of Reporting Person CO
___________________________________________________________________________
<PAGE> 3
This Amendment No. 4 amends the Statement on Schedule 13G (the
"Schedule 13G") of Hoechst Marion Roussel, Inc. ("HMRI", formerly named
Marion Merrell Dow Inc.) dated February 11, 1992, as amended through the
date hereof. This amendment is filed solely to report a change of record
ownership (but not ultimate beneficial ownership) of the outstanding stock
of HMRI and to adjust HMRI's percentage ownership of the Issuer's common
stock due to an increase in the number of shares of the Issuer's common
stock outstanding. Effective December 31, 1996, Hoechst Corporation
("HC"), a wholly-owned subsidiary of Hoechst Aktiengesellschaft, a German
corporation ("Hoechst AG"), conveyed its entire ownership interest in HMRI
to HMR Pharma, Inc. ("Pharma"), also a wholly-owned subsidiary of Hoechst
AG, in a reorganization among controlled affiliates of Hoechst AG.
Following the reorganization, Pharma's ownership interest in HMRI is
approximately 98 percent. Pharma has filed a Statement on Schedule 13D
with respect to its potential deemed beneficial ownership of the Issuer's
common stock as a result of Pharma's ownership of HMRI.
Item 4 of this Schedule 13G is hereby amended by inserting new
subsection (b) thereof as follows:
Item 4 Ownership
- ------ ---------
(b) Percent of Class: 8.4%
<PAGE> 4
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.
HOECHST MARION ROUSSEL, INC.
Date: February 6, 1997 By: /s/ Rebecca R. Tilden
-----------------------
Name: Rebecca R. Tilden
Title: Vice President, Assistant
General Counsel, and
Assistant Secretary
